semaglutide hidradenitis suppurativa GLP-1 agonists Semaglutide for Hidradenitis Suppurativa Safety

Semaglutide Phase 3 Results# Semaglutide's weight loss data come from the much larger STEP program: In STEP 1, 86.4% achieved at least 5% weight loss, 69.1% achieved at least 10%, and 50.5% achieved at least 15%

Water helps your digestive system work more smoothly and can alleviate bloating

While semaglutide can help avoid overeating, ophthalmologists emphasize that this is not a substitution for taking care of your overall health

Patients should discuss alternatives with a qualified healthcare professional if they have a personal or family history of medullary thyroid carcinoma or MEN 2, are currently pregnant or breastfeeding, have a history of pancreatitis, type 1 diabetes, or other serious medical conditions that may contraindicate GLP-1 use, prefer or require FDA-approved finished drug products rather than compounded medications, or have insurance coverage that may cover branded GLP-1 medications and want to explore that pathway first

Acute pancreatitis has been reported in association with GLP-1 receptor agonists, though a definitive causal relationship remains under investigation